Objective: To investigate the correlation between changes in brain activity associated with working memory and assessment scales of memory scores in amnestic mild cognitive impairment (aMCI) before and after moxibustion therapy.
Methods: aMCI patients were randomized into the moxibustion treatment (MT) group and the placebo moxibustion (PM) group. Each group received either moxibustion therapy or a placebo moxibustion for eight weeks.
The novel allele HLA-DPB1*04:01:15 is different from DPB1*04:01:01:01 with one nucleotide at nt 351 (C > A) in exon 2.
View Article and Find Full Text PDF